Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-11-04

Clinical Trial Update: Effect of Supplemental Intake of Omega-3 Polyunsaturated Fatty Acids on the Rate and Complexity of Spontaneously Occurring Ventricular and Supraventricular Arrhythmias in Patients With Implantable Cardioverter Defibrillator (ICD) - A Randomized Clinical Trial [Phase 4]

View source ↗

Summary

A randomized Phase 4 trial investigates whether supplemental omega-3 fatty acids affect the rate and complexity of ventricular and supraventricular arrhythmias …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 polyunsaturated fatty acids (supplement) (omega-3 fatty acids)

Snippet

Sponsor: Sheba Medical Center | Conditions: Coronary Artery Disease, Arrhythmia | Phase 4 | Status: UNKNOWN